Also trades as: CRDL.TO (TSX) · $vol 0M
CRDL Earnings
Cardiol Therapeutics Inc.
1W: -0.9%
1M: -32.5%
3M: -0.9%
YTD: +14.7%
1Y: -4.2%
3Y: +65.2%
5Y: -75.0%
$1.14
+0.02 (+1.79%)
Weekly Expected Move ±7.6%
$1
$1
$1
$1
$1
Credit Risk of going bust: lower than 89% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), Cardiol Therapeutics Inc. would be worth roughly what it owes.
Total debt $76K against a stock market value of $137.6M.
Distance to default 13.16 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $38K (short-term plus half of long-term), stock volatility 61.1%; Altman Z'' -23.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $76K against a stock market value of $137.6M.
Distance to default 13.16 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $38K (short-term plus half of long-term), stock volatility 61.1%; Altman Z'' -23.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-08-13
EPS
C$-0.04 (US$-0.03)
▲ Beat +55.6%
Revenue
—
EPS Beat Streak: 2 quarters
Next Earnings
2026-11-12
EPS Estimate
C$-0.10 (US$-0.07)
Range: C$-0.10 - C$-0.08
1 USD = 1.41 CAD
Estimate vs Actual
Earnings Surprise History
13/18
EPS Beats
0/18
Revenue Beats
72%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-26 | annual | 2030-12-31 | C$0.93 | C$0.93 | — | C$— | C$— |
| 2026-10-26 | annual | 2026-12-31 | C$-0.45 | C$-0.45 | — | C$1,127,500 | C$1,127,500 |
| 2026-10-26 | quarter | 2027-03-30 | C$-0.08 | C$-0.08 | — | C$— | C$— |
| 2026-10-26 | annual | 2027-12-31 | C$-0.32 | C$-0.32 | — | C$1,666,670 | C$1,666,670 |
| 2026-10-26 | quarter | 2027-12-30 | C$-0.06 | C$-0.06 | — | C$— | C$— |
| 2026-10-26 | quarter | 2027-06-30 | C$-0.06 | C$-0.06 | — | C$— | C$— |
| 2026-10-26 | annual | 2028-12-31 | C$-0.01 | C$-0.01 | — | C$74,094,785 | C$74,056,467 |
| 2026-10-26 | quarter | 2027-09-30 | C$-0.06 | C$-0.06 | — | C$— | C$— |
| 2026-10-26 | quarter | 2026-12-30 | C$-0.10 | C$-0.10 | — | C$— | C$— |
| 2026-10-26 | annual | 2029-12-31 | C$0.34 | C$0.34 | — | C$— | C$— |
| 2026-10-23 | annual | 2029-12-31 | C$0.34 | C$0.34 | — | C$— | C$— |
| 2026-10-23 | quarter | 2026-12-30 | C$-0.10 | C$-0.10 | — | C$— | C$— |
| 2026-10-23 | quarter | 2027-06-30 | C$-0.06 | C$-0.06 | — | C$— | C$— |
| 2026-10-23 | quarter | 2027-03-30 | C$-0.08 | C$-0.08 | — | C$— | C$— |
| 2026-10-23 | annual | 2028-12-31 | C$-0.01 | C$-0.01 | — | C$74,172,835 | C$74,094,785 |
Earnings Call Transcripts
No transcripts available.